2014 Oct – 2019 Apr | $450k

Optimization of Seasonal Malaria Chemoprevention (SMC) delivery and its effects on the acquisition of malaria immunity National Institute of Allergy and Infectious Diseases (NIAID), NIH, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Alassane Dicko | Mali

Similar Posts

  • DELGEME

    The Developing Excellence in Leadership and Genetics Training for Malaria Elimination in sub-Saharan Africa (DELGEME) is a training programme sponsored by the Wellcome Trust Developing Excellence in Leadership, Training and Science Africa (DELTAS Africa) initiative in partnership with the Department of International Development (DFID) and the Alliance for Accelerating Excellence in Science in Africa (AESA). …

  • 2013 Oct – 2014 Apr

    School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali National Center for Scientific and Technological Research (CNRST), Mali, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Ogobara Doumbo, Mahamadou S. Sissoko | Mali

  • Home: TMA – 2019 – Clinical Research and Product Development Fellowships

    EDCTP-Clinical Research and Product Development Fellow: Dr Amadou Hamidou Togo, MD, PhD, Université des Sciences Techniques et Technologiques de Bamako(USTTB), Faculty of Pharmacy (FAPH), Malaria Research and Training Center (MRTC) Grant Agreement number: TMA2019IF-2867 Grant Title: TMA2019 IF [ TOGO] Call for proposals: TMA2019 IF [ TOGO] The purpose of this Call for Proposals is to support researchers and members…

  • PfTBV-Consortuim

    Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…

  • WANECAM

    WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP). The WANECAM 2 project aims to accelerate the development of the  Ganaplacide/lumefantrine  combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries…

Leave a Reply

Your email address will not be published. Required fields are marked *